Precision Cancer Trials With Immunomodulatory Agents: Personalizing Histology Agnostic Approaches
We present a review and discussion of the progress in biomarker-defined approaches to drug development in immunology.
Source: The Cancer Journal - Category: Cancer & Oncology Tags: Review Articles Source Type: research
More News: Allergy & Immunology | Biology | Cancer | Cancer & Oncology | Clinical Trials | Food and Drug Administration (FDA) | Molecular Biology | Study